Weight loss of at least 5% at ≥ 12 months ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in DBP (mmHg) at ≥ 12 months · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
1 finding from 1 review
LDL cholesterol (mmol/L), change from baseline · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
1 finding from 1 review
Constipation at 3 to < 12 months ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in weight (kg) · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
2 findings from 1 review
Weight loss of at least 5% at ≥ 12 months ‐ not measured · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality ‐ not measured · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in DBP (mmHg) at ≥ 12 months · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
1 finding from 1 review
HbA1c (glycated haemoglobin), change · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
1 finding from 1 review
LDL cholesterol (mmol/L), change from baseline · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
1 finding from 1 review
Constipation at 3 to < 12 months ‐ not measured · overweight and obese participants with T2DM (weight‐reducing phase followed by weight‐maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in body weight (kg) at 3 to < 12 months ‐ not measured · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in weight (kg) · overweight and obese participants without T2DM (weight‐reducing phase followed by weight maintenance phase)
1 finding from 1 review
Death or bronchopulmonary dysplasia at 36 weeks PMA · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes death or BPD at 36 weeks PMA compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
BPD at 28 days · health problem or population
The review found no eligible studies for this question.
2 findings from 1 review
BPD (36 weeks' PMA) · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes BPD, defined as supplemental oxygen or positive pressure support use… compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
1 finding from 1 review
Treatment failure or need for mechanical ventilation · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes treatment failure or need for mechanical ventilation compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
2 findings from 1 review
Mortality before hospital discharge · health problem or population
It is very uncertain whether summary of Findings Table ‐ Low changes mortality, by hospital discharge compared with moderate‐high nasal continuous positive airway pressure levels (very low certainty).
2 findings from 1 review
Moderate‐severe neurodevelopmental impairment at 18 to 26 months ‐ not measured · health problem or population
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found